HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
6- (3- acetoxymethyl- 3- methyltriazenyl)- 4- (3'- bromophenylamino)quinazoline
has antineoplastic activity; degrades to RB14, RB10, and SR08 that have similar activity; structure in first source
Also Known As:
RB24 cpd
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Quinazolines: 402
6-(3-acetoxymethyl-3-methyltriazenyl)-4-(3'-bromophenylamino)quinazoline: 1
Organic Chemicals: 133
Triazenes: 36
6-(3-acetoxymethyl-3-methyltriazenyl)-4-(3'-bromophenylamino)quinazoline: 1
Experts
1.
Banerjee, Ranjita
: 1 article (07/2010)
2.
Huang, Ying
: 1 article (07/2010)
3.
Jean-Claude, Bertrand J
: 1 article (07/2010)
4.
McNamee, James P
: 1 article (07/2010)
5.
Todorova, Margarita
: 1 article (07/2010)
Related Diseases
1.
Breast Neoplasms (Breast Cancer)
07/01/2010 - "
6-(3-Acetoxymethyl-3-methyltriazenyl)-4-(3'-bromophenylamino)quinazoline (RB24) showed significant antiproliferative activity against human breast cancer cells, and transfection of one such cell line, MDA-MB-435, with ErbB1 or ErbB2 (Her2) dramatically enhanced cell death by apoptosis.
"